Thursday, March 11, 2010

Fitch Rating assigns Fresenius Kabi India Pvt Ltd a National Long term rating of 'BB+(ind)'

FK, a subsidiary of Fresenius SE ('BB'/Stable) (a global health care group), is focused on providing both inpatient and outpatient therapy and care for critically and chronically ill patients.

FKIPL operates FK;s operations in India and its infusion therapy products are manufactured at its plant in Pune (the only World Health Organization - Good Manufacturing Practices certified factory in Asia).

The infusion products are sold domestically as well as internationally, while the clinical therapy products and medical devices are imported for domestic consumption from FK's global product portfolio manufactured at its overseas plants.

To read more, please, visit Reuters

No comments: